1. Home
  2. SGRP vs AIMD Comparison

SGRP vs AIMD Comparison

Compare SGRP & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.75

Market Cap

18.2M

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$1.78

Market Cap

17.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
AIMD
Founded
1967
1984
Country
United States
United States
Employees
N/A
41
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.2M
17.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
AIMD
Price
$0.75
$1.78
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.8K
869.8K
Earning Date
03-31-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$136,104,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$0.45
52 Week High
$1.41
$4.50

Technical Indicators

Market Signals
Indicator
SGRP
AIMD
Relative Strength Index (RSI) 61.64 47.67
Support Level $0.74 $1.55
Resistance Level $0.80 $2.51
Average True Range (ATR) 0.04 0.47
MACD 0.00 -0.01
Stochastic Oscillator 70.56 18.48

Price Performance

Historical Comparison
SGRP
AIMD

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. The company provides five principal types of services: Merchandising, Marketing and Category Management, Remodel and Retail Transformation, Assembly and Installation, Fulfilment and Distribution, and Business Analytics and Insights. It operates in two segments, namely the U.S. and Canada, with the majority of the revenues deriving from the U.S. segment.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: